Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice parameter for inborn errors of immunity: What is new in the 2025 update.

The Journal of allergy and clinical immunology·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

The DNase TREX1 is a substrate of the intramembrane protease SPP with implications for disease pathogenesis.

Cellular and molecular life sciences : CMLS·2025
Same author

Gene therapy for inborn errors of immunity: Current clinical progress.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

Spectrum of clinical phenotypes of PLCG2 gene variants: Just PLAID.

The Journal of allergy and clinical immunology·2024
Same author

Insights from a single center registry of infant and toddler anaphylaxis: Food and fire ants.

The journal of allergy and clinical immunology. In practice·2023

Related Experiment Video

Updated: Jun 23, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: January 1, 2008

Advances in basic and clinical immunology.

Javier Chinen1, Fred Finkelman, William T Shearer

  • 1Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, 6621 Fannin Street MC:FC 330, Houston, TX 77030, USA. jchinen@bcm.edu

The Journal of Allergy and Clinical Immunology
|August 8, 2006
PubMed
Summary

This review highlights 2005 immunology advances, including innate and adaptive immune system interactions, T regulatory cell functions, and novel immunomodulatory flavonoids. Clinical progress includes newborn screening for severe combined immunodeficiency and new therapies for common variable immunodeficiency.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Related Experiment Videos

Last Updated: Jun 23, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: January 1, 2008

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
06:15

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Area of Science:

  • Basic and clinical immunology research.
  • Focus on innate and adaptive immune system interactions.
  • Exploration of T regulatory cells and immunomodulatory compounds.

Background:

  • Review of immunology articles published in 2005.
  • Emphasis on findings from the Journal of Allergy and Clinical Immunology.
  • Contextualizes advancements in immune system understanding and clinical applications.

Purpose of the Study:

  • To summarize key developments in basic and clinical immunology from 2005.
  • To highlight significant findings in immune system mechanisms and clinical interventions.
  • To provide an overview of the year's progress in allergy and clinical immunology.

Main Methods:

  • Literature review of published immunology articles from 2005.
  • Analysis of studies focusing on innate and adaptive immunity, T regulatory cells, and clinical immunology.
  • Identification of key findings in biodefense, autoimmune disorders, and immunodeficiency.

Main Results:

  • Characterization of T regulatory cells in controlling allergic, autoimmune, and neoplastic disorders.
  • Discovery of immunomodulatory properties in flavonoid molecules like astilbin and epigallocatechin gallate.
  • Advances in clinical immunology including newborn screening for severe combined immunodeficiency and insights into common variable immunodeficiency.

Conclusions:

  • Significant progress in understanding immune system regulation and its clinical implications.
  • Identification of novel therapeutic targets and strategies for immune-related disorders.
  • The year 2005 marked substantial contributions to both fundamental immunology and patient care.